David’s practice focuses on intellectual property and regulatory law. His regulatory practice is specific to the Canadian cannabis industry and to work with controlled substances. His clients include:
- Federal licence holders and applicants under the Cannabis Regulations
- Federal licence holders and applicants under Part J of the Food and Drug Regulations (restricted drugs)
- Technology companies
- Other domestic and foreign participants in the Canadian cannabis industry
David’s intellectual property practice and experience includes drafting and prosecuting patent applications, assessing patentability of technology, assessing validity of patents, assessing infringement of patents, patent-related due diligence, and multi-jurisdictional patent portfolio management.
David hold a PhD in biochemistry and his formal graduate-level education in structural biochemistry, organic chemistry, physical chemistry, plant biochemistry, and natural products chemistry provides a strong technical background for advising clients in the Canadian cannabis industry in relation to both intellectual property and regulatory law.
David is a Co-Chair of BLG’s National Cannabis Focus Group.